...Hoogheem. SMTG had been spending close to $1.5 million per month prior to the restructuring. Somatogen Inc....

...from now-defunct Northfield Laboratories Inc. , HemAssist from Baxter International Inc. and Optro rHb1.1 from Somatogen Inc....

...Corp. (CONX), Westminster, Colo. Business: Diagnostic, Cardiovascular Appointed: Charles Scoggin, former president and CEO of Somatogen Inc....

...$199.00 $175.30 $445.20 $360.10 $319.40 SkyePharma (LSE:SKP; SKYE) IPO 1/96 ($152.0M) $420.40 $529.00 $778.60 $468.80 Somatogen...
...$199.00 $175.30 $445.20 $360.10 $319.40 SkyePharma (LSE:SKP; SKYE) IPO 1/96 ($152.0M) $420.40 $529.00 $778.60 $468.80 Somatogen...

...engineered hemoglobin molecules being developed at its Baxter Hemoglobin Therapeutics Inc. subsidiary (Boulder, Colo.), formerly Somatogen Inc....

...Business: Diagnostics/Imaging Hired: Timothy Hoogheem as acting CFO, formerly VP of finance and administration at Somatogen Inc....

...II trials of its Optro rHb1.1 recombinant hemoglobin product, which Baxter inherited when it acquired Somatogen Inc....

...The company, formerly Somatogen Inc. , and colleagues published in Nature Biotechnology the synthesis of recombinant hemoglobin...

...With the exception of Baxter International Inc. 's purchase of Somatogen Inc. in February, pharmaceutical company acquisitions...

...and CEO, while remaining vice chairman of the board, formerly chairman, president and CEO of Somatogen Inc. WIR...